NETO1 Inhibitors

NETO1 inhibitors encompass a range of chemicals that primarily target the kainate subtype of glutamate receptors, reflecting NETO1's established role in modulating these receptors' activity. Compounds like ACET, UBP310 are characterized by their ability to bind to kainate receptors, acting as antagonists. By inhibiting kainate receptors, these compounds indirectly modulate the functional role of NETO1, which is closely tied to the optimal functioning and surface expression of these receptors.

Furthermore, some compounds exhibit a broader specificity, targeting not just kainate receptors but also AMPA receptors, as seen with CNQX and NBQX. While their primary targets might encompass a wider range of glutamate receptor subtypes, their influence on kainate receptors remains pertinent to NETO1's modulatory role. The recurrent theme among these inhibitors is their potential to alter the receptor activity that NETO1 is intrinsically associated with, thus presenting a method to indirectly modulate NETO1's functional effects in the context of neural signaling.